JTI Philippines Moves to New Office in Bonifacio Global City

JTI by 2FIRSTS.ai
Oct.31.2023
JTI Philippines Moves to New Office in Bonifacio Global City
JTI Philippines subsidiary has relocated to a new office in Bonifacio Global City, officiated by CEO Masamichi Terabatake.

According to reports, JTI's subsidiary in the Philippines has relocated to a new office in Bonifacio Global City.


Masamichi Terabatake, President and CEO of the JT Group, presided over the official inauguration ceremony of the new office, located on the 11th and 12th floors of the Ore Central Tower, at the corner of 31st Street and 9th Avenue.


In his speech, Masamichi Terahata stated that the new office is a symbol of JTI's success and also a recognition of the potential of the Philippine market, especially its people.


Japanese Ambassador to the Philippines, Koshikawa Kazuhiko, expressed that the opening of JTI's new office in the Philippines is another milestone for the company and a strong show of confidence in the country. Despite the prevailing pandemic, JTI remains committed to creating employment opportunities and supporting national development.


John Freda, General Manager of JTI Philippines, stated that this office is not just a new physical space, but rather a place that promotes team collaboration and encourages employees to give their best effort.


In addition, JTI has established a global business service processing office in McKinley West, with over 600 employees. They also have production facilities in Malvar, Rosario, and other places, with nearly 900 employees.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. FDA is publicly recruiting members for its Tobacco Products Scientific Advisory Committee, with nominations accepted from both individuals and organizations
The U.S. FDA is publicly recruiting members for its Tobacco Products Scientific Advisory Committee, with nominations accepted from both individuals and organizations
The U.S. FDA is soliciting voting members for the Tobacco Products Scientific Advisory Committee, with the nomination deadline set for August 25, 2025. This recruitment aims to fill five vacancies, including experts in the fields of oncology, pulmonology, cardiology, and others, as well as one representative from the general public and one from government employees. Selected members will serve a term of up to four years, beginning on February 1, 2026.
Jul.31 by 2FIRSTS.ai
VEIIK VITO: A Masterpiece in Your Palm, Crafted for the Extraordinary
VEIIK VITO: A Masterpiece in Your Palm, Crafted for the Extraordinary
Jun.18
U.S. Redding Police Conduct Tobacco Compliance Checks, Several Fined for Illegal Sales
U.S. Redding Police Conduct Tobacco Compliance Checks, Several Fined for Illegal Sales
U.S. Redding Police Intensify Crackdown on Illegal Tobacco Sales, Seize Over 600 Flavored Products, Emphasizing Youth Health and Safety.
Jul.25 by 2FIRSTS.ai
Product | VOZOL Launches Two New E-Cigarettes with 40,000 Puffs and Four-Level Adjustable Output
Product | VOZOL Launches Two New E-Cigarettes with 40,000 Puffs and Four-Level Adjustable Output
VOZOL has launched two new e-cigarette models, VISTA 40K and STAR 40K, on its official website following their debut at the 2025 Dubai Expo. Featuring 40,000 puffs, a 1000mAh battery, “quantified” flavor descriptions, display screens, and S.i.L.C. Tech dual mesh coils, the devices are now available on UK distributor websites VapeSourcing and Vape Cave.
Jul.10
Xinan Liu, Associate Researcher at the Brain Science Institute of CAS Shenzhen Institute of Advanced Technology, Speaks at 2Firsts Global NGP Rethink Forum
Xinan Liu, Associate Researcher at the Brain Science Institute of CAS Shenzhen Institute of Advanced Technology, Speaks at 2Firsts Global NGP Rethink Forum
Xinan Liu, Associate Researcher at the Brain Science Institute of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, delivered a keynote speech at the 2Firsts Global NGP Forum titled "The Global Opportunities and Challenges of The Novel Tobacco Industry from a Scientific Perspective".
Jul.30 by 2FIRSTS.ai
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
A U.S. federal court in Arizona has recently accepted a class-action lawsuit against Chinese e-cigarette manufacturer Smoore and its U.S. distributor. The suit accuses them of monopolizing the U.S. cannabis vape market through price manipulation and market division, resulting in higher costs for consumers. This marks the second such case filed this year.
Jul.03 by 2FIRSTS.ai